SGLT2 inhibitor administration to two patients with diabetes mellitus with ascites due to cirrhosis
We used the sodium-glucose cotransporter 2 inhibitor, luseogliflozin in two patients with diabetes mellitus with Child–Pugh classification B cirrhosis and cirrhotic ascites. In each case, luseogliflozin was safely used for over three years and was also considered effective in reducing ascites. In on...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Bioscientifica
2025-07-01
|
| Schriftenreihe: | Endocrinology, Diabetes & Metabolism Case Reports |
| Schlagworte: | |
| Online-Zugang: | https://edm.bioscientifica.com/view/journals/edm/2025/3/EDM-25-0015.xml |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|